InvestSMART

Medical Developments International Limited (ASX: MVP) - Announcements

Current share price for MVP : $0.405 0.01 (2.41%)+

ASX company news and announcements for Medical Developments International Limited (MVP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medical Developments International Limited (MVP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medical Developments International Limited (MVP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medical Developments International Limited (MVP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$46 MVP Announces FY25 Full Year Results 21 Aug 2025 8:57AM $0.635 $0.405 fallen by 36.22%
$46 FY25 Full Year Results 21 Aug 2025 8:57AM $0.635 $0.405 fallen by 36.22%
$46 FY25 Full Year Results Investor Presentation 21 Aug 2025 8:55AM $0.635 $0.405 fallen by 36.22%
$46 Date of AGM and Closing Date for Director Nominations 20 Aug 2025 12:18PM $0.700 $0.405 fallen by 42.14%
$46 FY25 Full Year Results Announcement Details 13 Aug 2025 9:27AM $0.740 $0.405 fallen by 45.27%
$46 Appendix 4C and Quarterly Activity Report - 30 June 2025 31 Jul 2025 10:03AM $0.660 $0.405 fallen by 38.64%
$46 Notification regarding unquoted securities - MVP 2 Jun 2025 5:39PM $0.670 $0.405 fallen by 39.55%
$46 Initial Director's Interest Notice 30 May 2025 10:04AM $0.650 $0.405 fallen by 37.69%
$46 Director Appointment and Resignation 30 May 2025 9:10AM $0.650 $0.405 fallen by 37.69%
$46 Appendix 4C and Quarterly Activity Report - 31 March 2025 29 Apr 2025 9:19AM $0.465 $0.405 fallen by 12.90%
$46 Initial Director's Interest Notice - M. Fladrich 1 Apr 2025 9:51AM $0.555 $0.405 fallen by 27.03%
$46 Appointment of Director - Mark Fladrich 21 Mar 2025 12:26PM $0.645 $0.405 fallen by 37.21%
$46 FY25 Half Year Announcement 20 Feb 2025 8:22AM $0.765 $0.405 fallen by 47.06%
$46 FY25 Half Year Presentation 20 Feb 2025 8:21AM $0.765 $0.405 fallen by 47.06%
$46 FY25 Half Year Report (including Appendix 4D) 20 Feb 2025 8:21AM $0.765 $0.405 fallen by 47.06%
$46 FY25 Half Year Results Announcement Details 12 Feb 2025 12:47PM $0.780 $0.405 fallen by 48.08%
$46 Appendix 4C and Quarterly Activity Report -31 December 2024 31 Jan 2025 8:18AM $0.440 $0.405 fallen by 7.95%
$46 Final Director's Interest Notice M. Sontrop 23 Dec 2024 10:42AM $0.405 $0.405 fallen by 0%
$46 MVP Investor Presentation - Bell Potter Conference 20 Nov 2024 10:53AM $0.425 $0.405 fallen by 4.71%
$46 Director Resignation Mary Sontrop 14 Nov 2024 8:49AM $0.435 $0.405 fallen by 6.90%
$46 2024 Annual General Meeting Webcast Recording 28 Oct 2024 3:22PM $0.460 $0.405 fallen by 11.96%
$46 Notice of Initial Substantial Holder 24 Oct 2024 5:21PM $0.470 $0.405 fallen by 13.83%
$46 Results of 2024 Annual General Meeting 24 Oct 2024 2:45PM $0.460 $0.405 fallen by 11.96%
$46 2024 Annual General Meeting Presentation 24 Oct 2024 11:29AM $0.495 $0.405 fallen by 18.18%
$46 2024 Annual General Meeting Chair and CEO address 24 Oct 2024 11:29AM $0.495 $0.405 fallen by 18.18%

26 - 50 of 613 results

Page 2 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.